The study further demonstrated that combination therapy led to a marked increase in ER stress markers, including BiP, CHOP, ATF-4, and the phosphorylation of eIF2α and PERK, with the effect being more pronounced in CRC cells. The gene discussed is HSPA5; the disease is colorectal carcinoma.